Skip to search formSkip to main contentSkip to account menu

capravirine

Known as: (5-(3,5-dichlorophenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)imidazol-2-yl)methyl aminoformate, 1H-Imidazole-2-methanol, 5-((3,5-dichlorophenyl)thio)-4-(1-methylethyl)-1-(4-pyridinylmethyl)-, carbamate (ester), 5-((3,5-Dichlorophenyl)thio)-4-isopropyl-1-(4-pyridylmethyl)imidazole-2-methanol Carbamate (ester) 
A non-nucleoside reverse transcriptase inhibitor. Capravirine shows antiviral activity against wild-type HIV as well as HIV strains with mutations in… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Capravirine (S-1153, AG1549), a 1,2,4,5-tetrasubstituted imidazole derivative, was firstly reported by the Shionogi company to… 
2008
2008
The discovery of new therapies for the treatment of delayed gastric emptying represents an opportunity to offer improved… 
2007
2007
Metabolism of [14C]capravirine was studied via both in vitro and in vivo means in rats and dogs. Mass balance was achieved in… 
2007
2007
Six tetra- and two penta-oxygenated capravirine metabolites observed in rats, dogs and humans represent the maximum numbers of… 
2004
2004
Capravirine is a nonnucleoside reverse-transcriptase inhibitor (NNRTI) with a unique resistance profile. Although single… 
Review
2004
Review
2004
Issues, such as complexity, tolerability, and drug resistance and cross-resistance, limit the effectiveness of current… 
2003
2003
Introduction of highly active antiretroviral therapy (HAART) including reverse transcriptase (RT) inhibitors has been effective… 
2003
2003
L'invention concerne une methode de traitement amelioree d'une infection par le VIH, consistant a administrer a un humain…